CYTOMEDIX INC COM NEW
GTF
GTF was delisted on the 25th of January, 2011.
0 hedge funds and large institutions have $0 invested in CYTOMEDIX INC COM NEW in 2014 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $15K → $0 (-$15K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Edge Wealth Management
New York
|
-$11K |
| 2 |
JIC
Joel Isaacson & Co
New York
|
-$4K |
GTF Hedge Fund Activity: Q4 2014 in Review
0 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CYTOMEDIX INC COM NEW (GTF) for Q4 2014, worth a combined $0 — down 100% from $15K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of GTF and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Edge Wealth Management, exiting entirely with an estimated $11K sold.
- 0 institutional investors held CYTOMEDIX INC COM NEW (GTF) as of Q4 2014, down from 2 in Q3 2014.
- Funds reported $0 of CYTOMEDIX INC COM NEW stock for Q4 2014, down 100% quarter-over-quarter.
- 0 funds opened new CYTOMEDIX INC COM NEW positions in Q4 2014 and 2 closed out, a net change of -2 holders.
- The largest CYTOMEDIX INC COM NEW seller in Q4 2014 was Edge Wealth Management, an estimated $11K sold.
Based on aggregated 13F filings for Q4 2014.